Are environmental contaminants responsible for ‘globesity’?

• Autorzy: Filipiak-Florkiewicz A. , Topolska K. , Florkiewicz A. , Cieslik E.
• Języki publikacji: EN

Abstrakty

EN

According to the World Health Organization (WHO), worldwide obesity has nearly doubled since 1980. In the previous year 42 million children under the age of 5 were overweight or obese. The concern of governments, the scientific community, and health services is noticed in the causes behind the prevalence of obesity and its prevention. Taking into consideration the reasons underlying obesity, toxic substances found in the environment and the food system have been receiving significant attention. Thus, the aim of this paper was to explore the associations between numerous environmental contaminants (heavy metals, persistent organic pollutants) and obesity. Our hypothesis was that neuroendocrine system disturbances caused by these xenobiotics play a crucial role in the obesity epidemic. The neurotoxicity of these compounds could be connected with the reward center in the brain as well as the endocrine system, and lead to an increase of food intake and, consequently, obesity. Taking into consideration global health as well as the best interests of society, studies in this area are crucial for understanding this problem.

• Wydawca: -
• Czasopismo: Polish Journal of Environmental Studies
• Rocznik: 2017
• Tom: 26
• Numer: 2
• Opis fizyczny: P.467-478,ref.

Twórcy

autor

Filipiak-Florkiewicz A.

• Department of Nutrition Technology and Consumption, Faculty of Food Technology, University of Agriculture in Krakow, 30-149 Krakow, Balicka S122, Poland

autor

Topolska K.

• Department of Nutrition Technology and Consumption, Faculty of Food Technology, University of Agriculture in Krakow, 30-149 Krakow, Balicka S122, Poland

autor

Florkiewicz A.

• Department of Food Analysis and Quality Assessment, Faculty of Food Technology, University of Agriculture in Krakow, 30-149 Krakow, Balicka 122, Poland

autor

Cieslik E.

• Department of Nutrition Technology and Consumption, Faculty of Food Technology, University of Agriculture in Krakow, 30-149 Krakow, Balicka S122, Poland

Bibliografia

• 1. KELISHADI R., POURSAFA P. Obesity and air pollution: global risk factors for pediatric non-alcoholic fatty liver disease. Hepat. Mon. 11 (10), 794-802, 2011.
• 2. WEICHENTHAL S., HOPPIN J.A., REEVES F. Obesity and the cardiovascular health effects of fine particulate air pollution. Obesity. 22 (7), 1580, 2014.
• 3. YACH D., STUCKLER D., BROWNELL K.D. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nature Medicine. 12, 62, 2006.
• 4. ELOBEID M.A., BROCK D.W., ALLISON D.B., PADILLA M.A., RUDEN D.M. Endocrine Disruptors and Obesity: An Examination of Selected Persistent Organic Pollutants in the NHANES 1999-2002 Data. Int. J. Environ. Res. Public. Health. 7 (7), 2988, 2010.
• 5. DE ONIS M., BLOSSNER M., BORGHI E. Global prevalence and trends of overweight and obesity among preschool children. Am. J. Clin. Nutr. 92 (5), 1257, 2010.
• 6. LEE D.H., STEFFES M.W., SJÖDIN A., JONES R.S., NEEDHAM L.L., JACOBS Jr. D.R. Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes. PLoS One. 6 (1), article ID: e15977, 2011.
• 7. HYMAN M.A. Environmental toxins, obesity, and diabetes: an emerging risk factor. Altern. Ther. Health. Med. 16 (2), 56, 2010.
• 8. GRÜN F., BLUMBERG B. Endocrine disrupters as obesogens. Mol. Cell. Endocrinol. 304 (1-2), 19, 2009.
• 9. NEWBOLD R.R., PADILLA-BANKS E., JEFFERSON W.N. Environmental estrogens and obesity. Mol. Cell. Endocrinol. 304 (1-2), 84, 2009.
• 10. AITLHADJ L., ÁVILA D.S., BENEDETTO A., ASCHNER M., STÜRZENBAUM S.R. Environmental exposure, obesity, and Parkinson’s disease: lessons from fat and old worms. Environ. Health. Perspect. 119 (1), 20, 2011.
• 11. LEE D.H. Persistent organic pollutants and obesityrelated metabolic dysfunction: focusing on type 2 diabetes. Epidemiol. Health. 34, article ID: e2012002, 2012.
• 12. BERK M., WILLIAMS L.J., ANDREAZZA A.C., PASCO J.A., DODD S., JACKA F.N., MOYLAN S., REINER E.J., MAGALHAES P.V.S. Pop, heavy metal and the blues: secondary analysis of persistent organic pollutants (POP), heavy metals and depressive symptoms in the NHANES National Epidemiological Survey. BMJ Open. 4 (7), 1, 2014.
• 13. GRÜN F., BLUMBERG B. Minireview: The Case for Obesogens. Molr. Endocrinol. 23 (8), 1127, 2009.
• 14. BUHMANN H., LE ROUX C.W., BUETER M. The gutbrain axis in obesity. Best Pract. Res. Clin. Gastroenterol. 28 (4), 559, 2014.
• 15. MATTERI R.L., CARROLL J.A., DYER C.J. Neuroendocrine Responses to Stress. The Biology of Animal Stress. 2000.
• 16. MARTINS I.J., CREEGAN R., LIM W.L.F., MARTINS R.N. Molecular Insights into Appetite Control and Neuroendocrine Disease as Risk Factors for Chronic Diseases in Western Countries. OJEMD. 3, 11, 2013.
• 17. VAN DEN POL A.N. Weighing the role of hypothalamic feeding neurotransmitters. Neuron. 40 (6), 1059, 2003.
• 18. ZHANG Y., LIU J., YAO J., JI G., QIAN L., WANG J., ZHANG G., TIAN J., NIE Y., ZHANG Y.E., GOLD M.S., LIU Y. Obesity: pathophysiology and intervention. Nutrients. 6 (11), 5153, 2014.
• 19. WANG G.J., VOLKOW N.D., LOGAN J., PAPPAS N.R., WONG C.T., ZHU W., NETUSIL N., FOWLER J.S. Brain dopamine and obesity. Lancet. 357 (9253), 354, 2001.
• 20. WANG G.J., VOLKOW N.D., THANOS P.K., FOWLER J.S. Imaging of brain dopamine pathways: implications for understanding obesity. J. Addict. Med. 3 (1), 8, 2009.
• 21. DROŻAK J., BRYŁA J. Dopamine: not just a neurotransmitter. Postepy Hig. Med. Dosw. (online). 59, 405, 2005 [In Polish].
• 22. GAINETDINOV R.R. Mesolimbic dopamine in obesity and diabetes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293 (2), R601, 2007.
• 23. ALSIÖ J., OLSZEWSKI P.K., LEVINE A.S., SCHIÖTH H.B. Feed-forward mechanisms: Addiction-like behavioral and molecular adaptations in overeating. Front Neuroendocrinol. 33 (2), 127, 2012.
• 24. BLUM K., KOZLOWSKI G.P. Ethanol and neuromodulator interactions: a cascade model of reward. Prog. Alchohol Res. 2, 131, 1990.
• 25. BLUM K., BRAVERMAN E.R., HOLDER J.M., LUBAR J.F., MONASTRA V.J., MILLER D., LUBAR J.O., CHEN T.J., COMINGS D.E. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J. Psychoactive Drugs. 32 (i-iv), S1-112, 2000.
• 26. JORANBY L., PINEDA K.F., GOLD M.S. Addiction to food and brain reward systems. Sex. Addict Compuls. 12 (2-3), 201, 2005.
• 27. KEEN-RHINEHART E., ONDEK K., SCHNEIDER J.E. Neuroendocrine regulation of appetitive ingestive behavior. Front. Neurosci. 7, 213, 2013.
• 28. BLUM K., LIH-CHUAN CHEN A., BRAVERMAN E.R., COMINGS D.E., CHEN T.J.H., ARCURI V., BLUM S.H., DOWNS B.W., WAITE R.L., NOTARO A., LUBAR J., WILLIAMS L., PRIHODA T.J., PALOMO T., OSCAR-BERMAN M. Attention-defi cit-hyperactivity disorder and reward deficiency syndrome. Neuropsychiatr. Dis. Treat. 4 (5), 893, 2008.
• 29. BLUM K., OSCAR-BERMAN M., STULLER E., MILLER D., GIORDANO J., MORSE S., MCCORMICK L., DOWNS W., WAITE R.L., BARH D., NEAL D., BRAVERMAN E.R., LOHMANN R., BORSTEN J., HAUSER M., HAN D., LIU Y., HELMAN M., SIMPATICO T. Neurogenetics and nutrigenomics of neuro-nutrient therapy for reward deficiency syndrome (RDS): Clinical ramifications as a function of molecular neurobiological mechanisms. J. Addict. Res. Ther. 3 (5), 139, 2012.
• 30. BLUM K., FEBO M., DEMOTROVICS Z., BADGAIYAN R.D. Embracing reward deficiency syndrome (RDS) solution system: A genomic thrust. Int. Arch. Addict. Res. Med. 1 (1), 2015.
• 31. BLUM K, THANOS P.K., GOLD M.S. Dopamine and glucose, obesity, and reward deficiency syndrome. Front. Psychol. 5, 919, 2014.
• 32. DE MATOS FEIJÓ F., BERTOLUCI M.C., REIS C. Serotonin and hypothalamic control of hunger: a review. Rev. Assoc. Med. Bras. 57 (1), 74, 2011.
• 33. LA FLEUR S.E., SERLIE M.J. The interaction between nutrition and the brain and its consequences for body weight gain and metabolism; studies in rodents and men. Best Pract. Res. Clin. Endocrinol. Metab. 28 (5), 649, 2014.
• 34. ASHOR A.W., AL-GAREEB A.I. Serotonin and obesity. Mustansiriya Medical Journal. 11 (1), 99, 2012.
• 35. STICE E., YOKUM S., ZALD D., DAGHER A. Dopaminebased reward circuitry responsivity, genetics, and overeating. Curr. Top. Behav. Neurosci. 6, 81, 2011.
• 36. VUCETIC Z., KIMMEL J., TOTOKI K., HOLLENBECK E., REYES T.M. Maternal high-fat diet alters methylation and gene expression of dopamine and opioid-related genes. Endocrinology. 151 (10), 4756, 2010.
• 37. MADANI S., DE GIROLAMO S., MUÑOZ D.M., LI R., SWEENEY G. Direct effects of leptin on size and extracellular matrix components of human pediatric ventricular myocytes. Cardiovasc. Res. 69 (3), 716, 2006.
• 38. DOHERTY G.H. Obesity and the ageing brain: could leptin play a role in neurodegeneration? Curr. Gerontol. Geriatr. Res. 2011, Article ID 708154, 8 pages, 2011.
• 39. WIMALAWANSA S. Pathophysiology of obesity: Focused, cause-driven approach to control the epidemic. Glo. Adv. Res. J. Pharm. Pharmacol. 2 (1), 002, 2013.
• 40. LOH K., FUKUSHIMA A., ZHANG X., GALIC S., BRIGGS D., ENRIORI P.J., SIMONDS S., WIEDE F., REICHENBACH A., HAUSER C., SIMS N.A., BENCE K.K., ZHANG S., ZHANG Z.Y., KAHN B.B., NEEL B.G., ANDREWS Z.B., COWLEY M.A., TIGANIS T. Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance. Cell. Metab. 14 (5), 684, 2011.
• 41. STASENKO S., BRADFORD E.M., PIASEK M., HENSON M.C., VARNAI V.M., JURASOVIĆ J., KUŠEC V. Metals in human placenta: focus on the effects of cadmium on steroid hormones and lepton. J. Appl. Toxicol. 30 (3), 242, 2010.
• 42. ATAMER Y., KOCYIGIT Y., YOKUS B., ATAMER A., ERDEN A.C. Lipid peroxidation, antioxidant defense, status of trace metals and leptin levels in preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 119 (1), 60, 2005.
• 43. JANESICK A., BLUMBERG B. Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. Birth. Defects. Res. C. Embryo. Today. 93 (1), 34, 2011.
• 44. RHIND S.M. Anthropogenic pollutants: a threat to ecosystem sustainability? Philos. Trans. R. Soc. Lond. B. Biol. Sci. 364 (1534), 3391, 2009.
• 45. JÄRUP L. Hazards of heavy metal contamination. Br. Med. Bull. 68, 167, 2003.
• 46. WHO Report. Preventing disease through healthy environments. Towards an estimate of the environmental burden of disease. (A. Prüss-Üstünand and C. Corvalán). ISBN 92 4 159382 2, 2006.
• 47. GONG M., WU L., BI X.Y., REN L.M., WANG L., MA Z.D., BAO Z.Y., LI Z.G. Assessing heavy-metal contamination and sources by GIS-based approach and multivariate analysis of urban-rural top soils in Wuhan, central China. Environ. Geochem. Health. 32 (1), 59, 2010.
• 48. LUO X.S., YU S., ZHU Y.G., LI X.D. Trace metal contamination in urban soils of China. Sci. Total. Environ. 421-422, 17, 2012.
• 49. WHO Statement Lead and Cadmium: Need for International Action? IFCS/FSC/WG Lead and Cadmium/09. Prepared by The Center for International Environmental Law (CIEL) On behalf of the Government of Germany/Lead Sponsor, 2008.
• 50. WHO Report. Health risks of heavy metals from long-range transboundary air pollution. ISBN 978 92 890 7179 6, 2007.
• 51. WHO Report. Childhood Lead Poisoning. ISBN 978 92 4 150033 3, 2010.
• 52. EJAZ UL I., XIAO-E Y., ZHEN-LI H., QAISAR M. Assessing potential dietary toxicity of heavy metals in selected vegetables and food crops. J. Zhejiang. Univ. SCI B. 8 (1), 1, 2007.
• 53. RICE D., BARONE S. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ. Health. Perspect. 108 (3), 511, 2000.
• 54. PRONCZUK J., SURDUB S. Children’s Environmental Health in the Twenty-First Century Challenges and Solutions. Ann. N. Y. Acad. Sci. 1140, 143, 2008.
• 55. AMAYA E., GIL F., FREIRE C., OLMEDO P., FERNANDEZ-RODRIGUEZ M., FERNANDEZ M.F., OLEA N. Placental concentrations of heavy metals in a mother-child cohort. Environ. Res. 120, 63, 2013.
• 56. FOWLER B.A. Monitoring of human populations for early markers of cadmium toxicity: a review. Toxicol. Appl. Pharmacol. 238 (3), 294, 2009.
• 57. ABDULLAH M.M., LY A.R., GOLDBERG W.A., CLARKE-STEWART K.A., DUDGEON J.V., MULL CH.G., CHAN T.J., KENT E.E., MASON A.Z., ERICSON J.E. Heavy metal in children’s tooth enamel: Related to autism and disruptive behaviors? J. Autism. Dev. Disord. 42 (6), 929, 2012.
• 58. FELDMAN R.G. Occupational neurology. Yale. J. Biol. Med. 60 (2), 179, 1987.
• 59. FELDMAN R.G. Occupational and environmental neurotoxicology. Philadelphia, Lippincott-Raven, 1999.
• 60. BOUCHARD M.F., SAUVÉ S., BARBEAU B., LEGRAND M., BRODEUR M.È., BOUFFARD T., LIMOGES E., BELLINGER D.C., MERGLER D. Intellectual impairment in school-age children exposed to manganese from drinking water. Environ. Health. Perspect. 119 (1), 138, 2011.
• 61. GUILARTE T.R. Manganese and Parkinson’s disease: a critical review and new findings. Environ. Health. Perspect. 118 (8), 1071, 2010.
• 62. LANPHEAR B.P., HORNUNG R., KHOURY J., YOLTON K., BAGHURST P., BELLINGER D.C., CANFIELD R.L., DIETRICH K.N., BORNSCHEIN R., GREENE T., ROTHENBERG S.J., NEEDLEMAN H.L., SCHNAAS L., WASSERMAN G., GRAZIANO J., ROBERTS R. Low level environmental lead exposure and children’s intellectual function: an international pooled analysis. Environ. Health. Perspect. 113 (7), 894, 2005.
• 63. TOSCANO C.D., GUILARTE T.R. Lead neurotoxicity: from exposure to molecular effects. Brain. Res. Brain. Res. Rev. 49 (3), 529, 2005.
• 64. NEAL A.P., GUILARTE T.R. Mechanisms of Heavy Metal Neurotoxicity: Lead and Manganese. J. Drug. Metab. Toxicol. S5:002, doi:10.4172/2157-7609.S5-002, 2012.
• 65. WHO Report. Children’s exposure to mercury compounds. ISBN 978 92 4 150045 6, 2010.
• 66. BERK M., KAPCZINSKI F., ANDREAZZA A.C., DEANA O.M., GIORLANDOA F., MAES M., YÜCEL M., GAMA C.S., DODDA S., DEAND B., MAGALHÃES P.V.S., AMMINGER P., MCGORRY P., MALHI G.S. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci. Biobehav. Rev. 35 (3), 804, 2011.
• 67. MOYLAN S., MAES M., WRAY N.R., BERK M. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol. Psychiatry. 18 (5), 595, 2013.
• 68. KURSULA P., MAJAVA V. A structural insight into lead neurotoxicity and calmodulin activation by heavy metals. Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun. 63 (Pt 8), 653, 2007.
• 69. REDDY G.R., DEVI B.C., CHETTY C.S. Developmental lead neurotoxicity: alterations in brain cholinergic system. Neurotoxicology. 28 (2), 402, 2007.
• 70. STANLEY P.C., WAKWE V.C. Toxic trace metals in the mentally ill patients. Niger Postgrad. Med. J. 9 (4), 199, 2002.
• 71. WHO Report. Global health risks: mortality and burden of disease attributable to selected major risks. ISBN 978 92 4 156387 1, 2009.
• 72. LA MERRILL M., BIRNBAUM L.S. Childhood Obesity and Environmental Chemicals. Mt. Sinai. J. Med. 78 (1), 22, 2011.
• 73. National Obesity Observatory. Body Mass Index as a measure of obesity. Available at: www.noo.org.uk/uploads/doc789_40_noo_BMI.pdf; 2009.
• 74. FREEDMAN D.S., SHERRY B. The validity of BMI as an indicator of body fatness and risk among children. Pediatrics. 124 (1), S23, 2009.
• 75. SHAH N.R., BRAVERMAN E.R. Measuring Adiposity in Patients: The Utility of Body Mass Index (BMI), Percent Body Fat, and Leptin. PLoS ONE. 7 (4), e33308, 2012.
• 76. BOSE-O’REILLY S., MCCARTY K.M., STECKLING N., LETTMEIER B. Mercury Exposure and Children’s Health. Curr. Probl. Pediatr. Adolesc. Health Care. 40 (8), 186, 2010.
• 77. MODGIL S., LAHIRI D.K., SHARMA V.L., ANAND A. Role of early life exposure and environment on neurodegeneration: implications on brain disorders. Transl. Neurodegener. 3:9, doi:10.1186/2047-9158-3-9, 2014.
• 78. MENDEZ-ARMENTA M., RIOS C. Cadmium neurotoxicity. Environ. Toxicol. Phar. 23 (3), 350, 2007.
• 79. ABU-TAWEEL G.M., AJAREM J.S., AHMAD M. Protective effect of curcumin on anxiety, learning behavior, neuromuscular activities, brain neurotransmitters and oxidative stress enzymes in cadmium intoxicated mice. J. Behav. Brain. Sci. 3 (1), 74, 2013.
• 80. HRDINA P.D., PEETRS D.A., SINGHAL R.L. Effects of chronic exposure to cadmium, lead and mercury of brain biogenic amines in the rat. Res. Commun. Chem. Pathol. Pharmacol. 15 (3), 483, 1976.
• 81. ANDERSON H., PETERSEN-GREVE K., LINDQUIST J., LUTHMAN J., OSKARSSON A., OLSON L. Low-level cadmium exposure of lactating rats causes alteration of brain serotonin level in the offspring. Neurotoxicol. Teratol. 19 (2), 105, 1977.
• 82. CHANDRA S.V., KALIA K., HUSSAIN T. Biogenic amines and some metals in brain of cadmium-exposed diabetic rats. J. Appl. Toxicol. 5 (6), 378, 1985.
• 83. DAS K.P., DAS P.C., DASGUPTA S., DEY C.C. Serotoninergic-cholinergic neurotransmitters function in brain during cadmium exposure in protein restricted rat. Biol. Trace Elem. Res. 36 (2), 119, 1993.
• 84. NATION J.R., FRYE G.D., VON STULTZ J., BRATTON G.R. Effect of combined lead and cadmium exposure: changes in schedule-controlled responding and in dopamine, serotonin and their metabolites. Behav. Neurosci. 103 (5), 1108, 1989.
• 85. KAYEMBA-KAY’S S., GEARY M.P.P., PRINGLE J., RODECK CH.H., KINGDOM J.C.P., HINDMARSH P.C. Gender, smoking during pregnancy and gestational age influence cord leptin concentrations in newborn infants. Eur. J. Endocrinol. 159 (3), 217, 2008.
• 86. WANG G., CHEN Z., BARTELL T., WANG X. Early life origins of metabolic syndrome: The role of environmental toxicants. Curr. Environ. Health Rep. 1 (1), 78, 2014.
• 87. HYMAN M.A. Systems biology, toxins, obesity, and functional medicine. Altern. Ther. Health. Med. 13 (2), S134, 2007.
• 88. KRIMSKY S. Hormonal chaos: The scientific and social origins of the environmental endocrine hypothesis. Johns Hopkins University Press, Baltimore, USA, ISBN: 0-8018-6279-5, 2000.
• 89. SCHUH R.A., RICHARDSON J.R., GUPTA R.K., FLAWS J.A., FISKUM G. Effects of the organochlorine pesticide methoxychlor on dopamine metabolites and transporters in the mouse brain. Neurotoxicology. 30 (2), 274, 2009.
• 90. BURNS J.S., WILLIAMS P.L., SERGEYEV O., KORRICK S., LEE M.M., REVICH B., ALTSHUL L., DEL PRATO J.T., HUMBLET O., PATTERSON JR D.G., TURNER W.E., NEEDHAM L.L., STAROVOYTOV M., HAUSER R. Serum dioxins and polychlorinated biphenyls are associated with growth among Russian boys. Pediatrics. 127 (1), e59-68, 2011.
• 91. VALVI D., MENDEZ M.A., MARTINEZ D., GRIMALT J.O., TORRENT M., SUNYER J., VRIJHEID M. Prenatal concentrations of polychlorinated biphenyls, DDE, and DDT and overweight in children: a prospective birth cohort study. Environ. Health. Perspect. 120 (3), 451, 2012.
• 92. CUPUL-UICAB L.A., KLEBANOFF M.A., BROCK J.W., LONGNECKER M.P. Prenatal exposure to persistent organochlorines and childhood obesity in the U.S. collaborative perinatal project. Environ. Health. Perspect. 121 (9), 1103, 2013.
• 93. WARNER M., SCHALL R.A., HARLEY K.G., BRADMAN A., BARR D., ESKENAZI B. In Utero DDT and DDE Exposure and Obesity Status of 7-Year-Old MexicanAmerican Children in the CHAMACOS Cohort. Environ. Health. Perspect. 121 (5), 631, 2013.
• 94. ARREBOLA J.P., OCANA-RIOLA R., ARREBOLA-MORENO A.L., FERNANDEZ-RODRÍGUEZ M., MARTIN-OLMEDO P., FERNANDEZ M.F., OLEA N. Associations of accumulated exposure to persistent organic pollutants with serum lipids and obesity in an adult cohort from Southern Spain. Environ. Pollut. 195, 9, 2014.
• 95. DELVAUX I., VAN CAUWENBERGHE J., HOND E.D., SCHOETERS G., GOVARTS E., NELEN V., BAEYENS W., VAN LAREBEKE N., SIOEN I. Prenatal exposure to environmental contaminants and body composition at age 7-9 years. Environ. Res. 132, 24, 2014.
• 96. HØYER B.B., RAMLAU-HANSEN C.H., HENRIKSEN T.B., PEDERSEN H.S., GÓRALCZYK K., ZVIEZDAI V., JÖNSSON B.A.G., HEEDERIK D., LENTERS V., VERMEULEN R., BONDE J.P., TOFT G. Body mass index in young school-age children in relation to organochlorine compounds in early life: a prospective study. Int. J. Obes. 38 (7), 919, 2014.
• 97. TANG-PE´RONARD J.L., HEITMANN B.L., ANDERSEN H.R., STEUERWALD U., GRANDJEAN P., WEIHE P., JENSEN T.K. Association between prenatal polychlorinated biphenyl exposure and obesity development at ages 5 and 7 y: a prospective cohort study of 656 children from the Faroe Islands. Am. J. Clin. Nutr. 99 (1), 5, 2014.
• 98. DURCZOK A., SZKILNIK R., NOWAK P., LABUS Ł., DĄBROWSKA J., BORTEL A., ZAGZIŁ T., SWOBODA M., RYCERSKI W., WINNICKA H., KOSTRZEWA R.M., KWIECIŃSKI A., BRUS R. The effects of zinc on the central dopaminergic system of rats prenatally exposed to cadmium. Pol. J. Environ. Stud. 14 (5), 569, 2005.
• 99. MOOS T., MORGAN E.H. The metabolism of neuronal iron and its pathogenic role in neurological disease: Review. Ann. N. Y. Acad. Sci. 1012, 14, 2004.
• 100. El-Baky A.E.A. The role of curcuminoids in overcoming neurodegenerative disorders resulting from heavy metal overload. International JBPR. 1 (3), 110, 2012.
• 101. VELEZ-PARDO C., JIMENEZ DEL RIO M., VERSCHUEREN H., EBINGER G., VANQUELIN G. Dopamine and iron induce apoptosis in PC12 cells. Pharmacol. Toxicol. 80 (2), 76, 1997.
• 102. AIRAKSINEN R., RANTAKOKKO P., ERIKSSON J.G., BLOMSTEDT P., KAJANTIE E., KIVIRANTA H. Association between type 2 diabetes and exposure to persistent organic pollutants. Diabetes Care. 34 (9), 1972, 2011.
• 103. FERGUSON K.K., O’NEILL M.S., MEEKER J.D. Environmental contaminant exposures and preterm birth: A comprehensive review. J. Toxicol. Environ. Health. B: Criti. Rev. 16 (2), 69, 2013.
• 104. BLOCKER T.D., OPHIR A.G. Cryptic confounding compounds: A brief consideration of the influences of anthropogenic contaminants on courtship and mating behavior. Acta Ethol. 16 (2), 105, 2013.
• 105. HATCHER J.M., DELEA K.C., RICHARDSON J.R., PENNELL K.D., MILLER G.W. Disruption of dopamine transport by DDT and its metabolites. NeuroToxicology. 29 (4), 682, 2008.
• 106. KLAASSEN C.D., editor. Casarett & Doull’s toxicology: the basic science of poisons. New York, McGraw-Hill, 2001.
• 107. HEINDEL J.J. Endocrine disruptors and the obesity epidemic. Toxicol. Sci. 76 (2), 247, 2003.
• 108. NEWBOLD R.R., PADILLA-BANKS E., JEFFERSON W.N., HEINDEL J.J. Effects of endocrine disruptors on obesity. Int. J. Androl. 31 (2), 201, 2008.
• 109. EMOND C., BIRNBAUM L.S., DEVITO M.J. Use of a physiologically based pharmacokinetic model for rats to study the influence of body fat mass and induction of CYP1A2 on the pharmacokinetics of TCDD. Environ. Health. Perspect. 114 (9), 1394, 2006.
• 110. LONGNECKER M.P. Pharmacokinetic variability and the miracle of modern analytical chemistry. Epidemiology. 17 (4), 350, 2006.
• 111. JONES O.A., MAGUIRE M.L., GRIFFI J.L. Environmental pollution and diabetes: a neglected association. Lancet. 371 (9609), 287, 2008.
• 112. HUMBLET O., BIRNBAUM L., RIMM E., MITTLEMAN M.A., HAUSER R. Dioxins and cardiovascular disease mortality. Environ. Health. Perspect. 116 (11), 1443, 2008.
• 113. YAMAGISHI S.I., EDELSTEIN D., DU X.L., KANEDA Y., GUZMAN M., BROWNLEE M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J. Biol. Chem. 276 (27), 25096, 2001.
• 114. MARIUSSEN E., FONNUM F. Neurochemical targets and behavioral effects of organohalogen compounds: an update. Crit. Rev. Toxicol. 36 (3), 253, 2006.
• 115. BLOOMQUIST J.R., BARLOW R.L., GILLETTE J.S., LI W., KIRBY M.L. Selective effects of insecticides on nigrostriatal dopaminergic nerve pathways. Neurotoxicology. 23 (4), 537, 2002.
• 116. DEICHMANN W.B., MACDONALD W.E., CUBIT D.A., BEASLEY A.G. Effects of starvation in rats with elevated DDT and dieldrin tissue levels. Internationales Archiv für Arbeitsmedizin. 9 (3), 233, 1972.
• 117. VILLENEUVE D.C., VAN LOGTEN M.J., DEN TONKELAAR E.M., GREVE P.A., VOS J.G., SPEIJERS G.J., VAN ESCH G.J. Effect of food deprivation on low level hexachlorobenzene exposure in rats. Sci. Total. Environ. 8 (2), 179, 1977.
• 118. LIM S., AHN S.Y., SONG I.C., CHUNG M.H., JANG H.C., PARK K.S., LEE K.U., PARK Y.K., LEE H.K. Chronic exposure to the herbicide, atrazine, causes mitochondrial dysfunction and insulin resistance. PLoS One. 4 (4), e5186, 2009.
• 119. RUZZIN J., PETERSEN R., MEUGNIER E., MADSEN L., LOCK E.J., LILLEFOSSE H., MA T., PESENTI S., SONNE S.B., MARSTRAND T.T., MALDE M.K., DU Z.Y., CHAVEY C., FAJAS L., LUNDEBYE A.K., BRAND C.L., VIDAL H., KRISTIANSEN K., FRØYLAND L. Persistent organic pollutant exposure leads to insulin resistance syndrome. Environ. Health. Perspect. 118 (4), 465, 2010.
• 120. HATCH E.E., NELSON J.W., STAHLHUT R.W., WEBSTER T.F. Association of endocrine disruptors and obesity: perspectives from epidemiological studies. Int. J. Androl. 33 (2), 324, 2010.
• 121. RÖNN M. Environmental contaminants and obesity. Acta Universitatis Upsaliensis. Uppsala, ISBN 978-91-554-8798-0, 2013.
• 122. PROVOST T., KENNEDY M., CASTRACANE V.D., LEE A.M. The effects of polychlorinated biphenyl on circulating leptin and thyroid hormone status in Sprague-Dawley rats, Rattus norvegicus. Ohio J. Sci. 107 (2), 19, 2007.
• 123. ROCHESTER J.R. Bisphenol A and human health: A review of the literature. Reprod. Toxicol. 42, 132, 2013.
• 124. VANDENBERG L.N., EHRLICH S., BELCHER S.M., BEN-JONATHAN N., DOLINOY D.C., EHRLICH S. Low dose effects of bisphenol A: An integrated review of in vitro, laboratory animal and epidemiology studies. Endocrine Disruption. 1 (1), e25078-1-e25078-20, 2013.
• 125. VOM SAAL F.S., WELSHONS W.V. Evidence that bisphenol A (BPA) can be accurately measured without contamination in human serum and urine, and that BPA causes numerous hazards from multiple routes of exposure. Mol. Cell. Endocrinol. 398 (1-2), 101-113, 2014.
• 126. TAXVIG C., DREISIG K., BOBERG J., NELLEMANN C., SCHELDE A.B., PEDERSEN D., BOERGESEN M., MANDRUP S., VINGGAARD A.M. Differential effects of environmental chemicals and food contaminants on adipogenesis, biomarker release and PPARγ activation. Mol. Cell. Endocrinol. 361 (1-2), 106, 2012.
• 127. ARSENESCU V., ARSENESCU R.I., KING V., SWANSON H., CASSIS L.A. Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflammatory adipokines and promotes obesity and atherosclerosis. Environ. Health. Perspect. 116 (6), 761, 2008.
• 128. HENNIG B., ORMSBEE L., MCCLAIN C.J., WATKINS B.A., BLUMBERG B., BACHAS L.G., SANDERSON W., THOMPSON C., SUK W.A. Nutrition can modulate the toxicity of environmental pollutants: Implications in risk assessment and human health. Environ. Health. Perspect. 120 (6), 771, 2012.
• 129. BASHANDY S.A., ALHAZZA I.M. The hepatoprotective effect of β-carotene against cadmium toxicity in rats. J. Pharmacol. Toxicol. 3 (6), 457, 2008.
• 130. AL-ATTAR A.M. Vitamin E attenuates liver injury induced by exposure to lead, mercury, cadmium and copper in albino mice. Saudi. J. Biol. Sci. 18 (4), 395, 2011.
• 131. POLJŠAK B., FINK R. The protective role of antioxidants in the defence against ROS/RNS-mediated environmental pollution. Oxid. Med. Cell. Longev. 2014, 671539, 2014.
• 132. EL-BOSHY M.E., RISHA E.F., ABDELHAMID F.M., MUBARAK M.S., HADDA T.B. Protective effects of selenium against cadmium induced hematological disturbances, immunosuppressive, oxidative stress and hepatorenal damage in rats. J. Trace Elem. Med. Biol. 29, 104, 2014.
• 133. TAI C.C., DING S.T. N-3 polyunsaturated fatty acids regulate lipid metabolism through several inflammation mediators: mechanisms and implications for obesity prevention. J. Nutr. Biochem. 21 (5), 357, 2010.
• 134. KIM J., LI Y., WATKINS B.A. Endocannabinoid signaling and energy metabolism: a target for dietary intervention. Nutrition. 27 (6), 624, 2011.
• 135. VAN ELST V., BRUININGA H., BIRTOLI B., TERREAUXC C., BUITELAARD J.K., KAS M.J. Food for thought: Dietary changes in essential fatty acid ratios and the increase in autism spectrum disorders. Neurosci. Biobehav. Rev. 45, 369-378, 2014.
• 136. HONG M.Y., LUMIBAO J., MISTRY P., SALEH R., HOH E. Fish oil contaminated with persistent organic pollutants reduces antioxidant capacity and induces oxidative stress without affecting its capacity to lower lipid concentrations and systemic inflammation in rats. J. Nutr. 145 (5), 2015.
• 137. SMINK A., RIBAS-FITO N., GARCIA R., TORRENT M., MENDEZ M.A., GRIMALT J.O., SUNYER J. Exposure to hexachlorobenzene during pregnancy increases the risk of overweight in children aged 6 years. Acta Paediatr. 97 (10), 1465, 2008.
• 138.THIRUCHELVAM M., RICHFIELD E.K., GOODMAN B.M., BAGGS R.B., CORY-SLECHTA D.A. Development exposure to the pesticides paraquat and maneb and the Parkinson’s disease phenotype. Neurotoxicology. 23 (4-5), 621, 2002.
• 139. WHO Statement. Early life opportunities for the prevention of non-communicable disease in developing countries. 2011.
• 140. HUE O., MARCOTTE J., BERRIGAN F., SIMONEAU M., DORÉ J., MARCEAU P., MARCEAU S., TREMBLAY A., TEASDALE N. Increased plasma levels of toxic pollutants accompanying weight loss induced by hypocaloric diet or by bariatric surgery. Obes. Surg. 16 (9), 1145, 2006.

Identyfikatory

DOI

10.15244/pjoes/65427